https://vu364770agonist.com/lo....ng-term-connection-b
Frontline therapy encompass high intensity combo chemotherapy with good overall survival; however, relapsing/refractory clients have very limited choices. In the last many years, the understanding of molecular physiopathology of this disease, resulted in recognition of a subset of patients with peculiar genetic profile, particularly "early T-cell precursors" lymphoblastic leukemia, described as dismal outcome and indication to frontline allogeneic bone marro
Like
Comment
Share
